Invention Grant
US08669255B2 Substituted octahydropyrrolo[1,2-a]pyrazines as calcium channel blockers
有权
取代的八氢吡咯并[1,2-a]吡嗪作为钙通道阻断剂
![Substituted octahydropyrrolo[1,2-a]pyrazines as calcium channel blockers](/docs/US/2014-03-11/US08669255B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted octahydropyrrolo[1,2-a]pyrazines as calcium channel blockers
- Patent Title (中): 取代的八氢吡咯并[1,2-a]吡嗪作为钙通道阻断剂
-
Application No.: US13627541Application Date: 2012-09-26
-
Publication No.: US08669255B2Publication Date: 2014-03-11
- Inventor: Tao Li , Sachin V. Patel , Richard J. Perner , John T. Randolph , Michael R. Schrimpf , Kevin R. Woller , Zhiren Xia , Qingwei Zhang
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Main IPC: A61K31/495
- IPC: A61K31/495
![Substituted octahydropyrrolo[1,2-a]pyrazines as calcium channel blockers](/abs-image/US/2014/03/11/US08669255B2/abs.jpg.150x150.jpg)
Abstract:
The present application relates to: (a) compounds of Formula (I): and salts thereof, wherein Z1, Z2, Z3, Z4, R1, R2, and R3 are as defined in the specification; (b) compositions comprising such compounds and salts; and (c) methods of use of such compounds, salts, and compositions, particularly use as calcium channel inhibitors.
Public/Granted literature
- US20130085142A1 SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINES AS CALCIUM CHANNEL BLOCKERS Public/Granted day:2013-04-04
Information query
